Menu
ncarol.com
  • Home
  • Books
  • Book Release
  • Health
  • Business
  • Financial
  • Arts
  • Manufacturing
  • Real Estate
ncarol.com

Lenoir NC Company Files US Patent Application for "Voice-Activated Talk-Through Safety Mask Appliance and Method" dubbed, "VATTSMA™"
ncarol.com/10061312

Trending...
  • New ProEssentials v11: Native WinUI Charting Library, 100M Points in 15ms, Following Microsoft's Vision for True Native Swap-Chain Rendering
  • $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
  • 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
Inventors find 'Silver Lining in COVID-19 Cloud' with New Talk-Through Face Mask, Miniature Loudspeaker and Telecommunications Emitter Developed at University of Pittsburgh

KITTY HAWK, N.C. - ncarol.com -- Joyce Mann, Chairman and CEO of Lenoir-based RMANNCO, Inc., announced today that RMANNCO, Inc. has caused the formal filing of Letters Patent Application drawn to a new means and method of communication and biocontrol protection while wearing any kind of face covering, such as surgical masks, plastic face shields or cloth face.  The title of the invention is "Voice-Activated Talk-Through Safety Mask Appliance and Method", called, 'VATTSMA'™. See: https://doctorjoesoriginal.weebly.com/  The Inventors listed on the patent application are Ms. Joyce M. Mann and Dr. Joseph A. Resnick.

The new product has its foundations in three early patents issued by inventor, Resnick, while a student at the University of Pittsburgh Eye and Ear Hospital, Pittsburgh, PA where he developed 'The Resnick Tone Emitter', known as the 'Talking-Tooth', which issued as US Patent #4,571,739, Intraoral Electrolarynx; US Patent #4,706,292, Speech Prosthesis; and US Patent #5,015,179 Speech Monitor. See: https://tinyurl.com/y742blc7 . Dr. Joe Resnick, a former NASA Scholar and Research Scientist, said, "Parts of those prior technologies are used in the new VATTSMA™ product for which letters patent protection is pending approval.  Of particular value and use for the new product is the miniature loudspeaker and electronics 'chip' we developed at Pitt in the 1980's, as these are 'fluid-resistant' and won't be affected by moisture from breathing, talking, etc.  A value-added feature is that the electronics package is removable allowing its use on new masks once original masks have become soiled or unwanted".  Resnick continued, "As an 'Optimist', I like to find good outcomes in everything…even worst-case scenarios such as the COVID-19 Pandemic. I have always been aware of the problems communicating while wearing a surgical-type mask.  This was problematic when I was a student at Pitt, nearly 40 years ago…and has remained problematic to this day…even in my own work in my own laboratory.  Enter the new VATTSMA™ technology.  Now, people wearing masks equipped with the amplification emitter who work in health care, in hospitals, etc., or government officials giving speeches or having to talk in public, will be able to do so without removing the mask and their speech will be more intelligible, more audible at 83 dB, which is just a little louder than speech during normal communication. So, to quote the old sayings, 'Every cloud has a silver lining'.  And the VATTSMA™ technology represents a little piece of 'silver lining' that we have realized necessary and which fills a real-world need, despite this horrible Pandemic. 'Fortune favors the Bold'".

More on ncarol.com
  • FDA Food Recall Notices After Outbreak Linked to 98 Hospitalizations: Practical Tips for Safer Grocery Shopping
  • The 'Tax Squeeze': Betsson's Record Quarter Previews the Economics of Finland's 2027 Casino Market
  • Ten-Time Combat-Deployed U.S. Army Major Imprisoned For Telling The Truth In North Carolina Court Rm
  • ImagineX Acquires Payteros to Strengthen Digital Transformation Capabilities
  • From Pizza to Playlists: Marty The Pizza Guy Delivers Three Delicious New Songs

Since the declaration of the COVID-19 Pandemic by the World Health Organization in March 2020, most of the world's population has resorted to, or been mandated to, wearing some form of mask or face covering thought to help slow/stop the spread of the Corona Virus, COVID-19.  According to the US Department of Commerce more than 2 Billion safety masks have been produced and used since the outbreak of the Corona Virus in January 2020. The US Department of Commerce reports that more than 300 Million N-95 masks have been ordered by various US government agencies since March 2020 with the US Military ordering millions more.

Mann said that the initial price for the individual VATTSMA™ unit will be around $20.00, and that a test-market study is being orchestrated on the 'GoFundMe' Crowdfunding platform at https://tinyurl.com/yau4duub .  Mann said, "That price should drop, significantly, as large orders are received and the units can be contracted and sold at retail by the tens-of-thousands".  Mann said, "Yes, they may seem a bit pricey, at first.  But the retail price will fall, a function of supply and demand economics.  As we receive more and more orders and these are passed along to our manufacturers, the electronics component price will fall, drastically.  When that happens we will be able to offer the technology/masks for about the same retail price as an N-95 mask today".

Mann said that RMANNCO, Inc., Licensee to the technology, is actively seeking JV partners to assist with global marketing of the VATTSMA™ product line because the potential market size is so large.

More on ncarol.com
  • Adelaide's Army of Hope Celebrates 501(c)(3) Status Ahead of Swing Fore Hope Golf Tournament
  • Salestrics Introduces PraiseEngine: The AI-Native Review Engine Built to Fix Social Proof
  • NVM Pet Celebrates a Decade of Growth by Honoring the People Behind Its Success
  • Mike "The Situation" Sorrentino Celebrates Opening of Second Archangel Centers Location
  • Big Money Retirement Opens Dedicated Charlotte Office to Better Serve Growing Client Base

END

For Additional Information Contact:

Ms. Joy Mann, Chief Executive Officer
Email: Joy@rmannco.com
Phone: 478-244-2131
www.rmannco.com

Contact
RMANNCO, Inc.
Joyce M. Mann, CEO
nxgenusa@aol.com
8285727705


Source: RMANNCO, Inc.
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Crossroads4Hope Announces The Lipschutz Women's Fund
  • Handmade Coverlet Returns Home to Piedmont Crossing
  • AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
  • 91 Per Cent of Enterprises Will Increase AI Spending. Most Can't See the Cost — or the Risk!
  • VINCE Lifestyle Magazine Announces Virtual "Health, Wealth & Wellness Summit"
  • New ProEssentials v11: Native WinUI Charting Library, 100M Points in 15ms, Following Microsoft's Vision for True Native Swap-Chain Rendering
  • Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
  • Inlow Upholstery Offers Custom Boat Seat Reupholstery for Western North Carolina Lake Communities
  • Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
  • What's New in Hokkaido, Autumn 2026
  • Charlotte Investors Name Priority Property Group Among the City's Best Property Management Companies
  • Gospel Artist and Media Executive Trevone Perry Heads to the 41st Stellar Gospel Music Awards
  • KOLBUS America Welcomes New Sales Manager, Reid Crawley
  • CRG Awarded NASA SEWP VI Contracts in Categories B and C
  • Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year
  • Elevate Your Sneakers With Crep Protect Trek Laces
  • Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision
  • Humanbein Launches to Inspire Compassion Through Service, Opportunity, and Community
  • Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
  • DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
_catLbl0 _catLbl1

Popular on ncarol.com

  • RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project - 153
  • BumblebeeSmart Announces Partnership with Extreme Kids World to Expand Access to Sensory Wall Panels and Educational Busy Boards - 118
  • Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers - 113
  • UK Financial Ltd. Opens Test-Phase Maya 3 Liquidity Pool on Uniswap with DEX Screener Visibility for Market-Smoothing Ahead of CATEX Exchange Launch - 109
  • NextBoat's AI-Powered Marine Marketplace Gains Momentum as Record Growth Signals an Inflection Point for Investors (N Y S E American: NXB)
  • Director Sean McNamara Reunites with Award-Winning Cinematographer Shawn Seifert for Upcoming Feature Home
  • Landmark Construction Expands Glass, Glazing, and Commercial Remodeling Services Across Los Angeles County and Surrounding Areas
  • Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
  • From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
  • DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care

Similar on ncarol.com

  • FDA Food Recall Notices After Outbreak Linked to 98 Hospitalizations: Practical Tips for Safer Grocery Shopping
  • Mike "The Situation" Sorrentino Celebrates Opening of Second Archangel Centers Location
  • Handmade Coverlet Returns Home to Piedmont Crossing
  • VINCE Lifestyle Magazine Announces Virtual "Health, Wealth & Wellness Summit"
  • Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
  • DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
  • U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
  • Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
  • CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
  • Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute